Core Insights - NU Skin Enterprises Inc. reported revenue of $370.3 million, adjusted net income of $14.5 million, and adjusted EPS of $0.29, which were below estimates of $380.2 million, $15.1 million, and $0.30 respectively, indicating weaker-than-expected top-line results [1] - The results were at the low end of revenue guidance and the high end of EPS guidance, with a gross margin of 77.6% for the Nu Skin business [1] - Management emphasized strategic penetration into India and other emerging markets, along with margin expansion and a one-time tax benefit, as key contributors to the EPS results for FY25 [1] Financial Performance - Revenue from Rhyz was $48.52 million, comprising $42.45 million from Manufacturing and $6.07 million from Rhyz Other [1] - Selling expenses for the core business decreased to 40.8%, reflecting disciplined spending [1] Strategic Initiatives - Management remains focused on executing strategic initiatives despite the weaker top-line results [1] - The rollout of Prism iO is advancing with a pre-launch in India underway, and a full opening expected in the second half of FY26 [7] - FY26 EPS guidance is set at a midpoint of $1.00 [7]
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q4